Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07439666Not ApplicableNot Yet Recruiting

NEUROCUPLE™ as an Opioid Alternative Following Total Knee Arthroplasty

Role: collaborator

NCT07461506Not ApplicableNot Yet Recruiting

NeuroCuple to Mitigate Post-Wisdom Teeth Extraction Opioid Risks

Role: lead

NCT06460350Not ApplicableCompleted

NEUROCUPLE™ in TKA Patients to Enhance Pain Management

Role: lead

NCT07185425Not ApplicableRecruiting

Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery

Role: collaborator

NCT05252858Not ApplicableCompleted

A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery

Role: collaborator

NCT04753567Not ApplicableUnknown

nCap Pain Relief Patch vs. Placebo

Role: lead

All 6 trials loaded